Literature DB >> 31165547

Evaluation of the central pedicled, modified Wise-pattern technique as a standard level II oncoplastic breast-conserving surgery: A retrospective clinicopathological study of 190 breast cancer patients.

Péter Kelemen1, Dávid Pukancsik1, Mihály Újhelyi1, Eszter Kovács2, Alexia Stamatiou3, Gabriella Ivády4, István Kenessey5,6, Tibor Kovács7, Viktor Smanykó8, Gábor Rubovszky9, Zoltán Mátrai1.   

Abstract

Involving 207 breast cancer patients a retrospective study was performed to facilitate the acceptance of the central pedicled, modified Wise-pattern therapeutic mammoplasty technique as a standard volume-displacement level II oncoplastic breast-conserving surgery (OBCS). The overall local recurrence rate was 5.8% with an average follow-up of 43.9 months. The median time to the initiation of the adjuvant treatment was 4.9 weeks. Due to positive surgical margins, 13 (6.84%) completional surgeries were performed. In total, 45 complications (12.9%) were recorded. The median values of the esthetic outcomes represented improved cosmetic results. The modified Wise-pattern technique could be a standard, safe and repeatable level II volume-displacement OBCS.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast-conserving surgery; oncoplastic surgery; therapeutic mammoplasty

Mesh:

Year:  2019        PMID: 31165547     DOI: 10.1111/tbj.13371

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  2 in total

1.  The Tumor Plastic Surgery Technology versus Traditional Repair Technology on the Repair of Large-Area Skin Defects after Maxillofacial Tumor Resection: A Randomized Controlled Trial.

Authors:  Xue-Feng Zhang; Zheng Chu; Hong-Li Yang; Bing Zhao
Journal:  J Oncol       Date:  2022-05-26       Impact factor: 4.501

2.  Outcome reporting in therapeutic mammaplasty: a systematic review.

Authors:  Alice Lee; Richard M Kwasnicki; Hasaan Khan; Yasmin Grant; Abigail Chan; Angela E E Fanshawe; Daniel R Leff
Journal:  BJS Open       Date:  2021-11-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.